Literature DB >> 11443625

Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

Y S Chun1, N M Lindor, T C Smyrk, B T Petersen, L J Burgart, P J Guilford, J H Donohue.   

Abstract

BACKGROUND: The CDH1 gene encodes E-cadherin, an epithelial cell adhesion molecule. Germline CDH1 mutations recently were identified in families with hereditary diffuse gastric carcinoma in a pattern suggestive of autosomal dominant inheritance with incomplete penetrance.
METHODS: The proband was a woman age 47 years with a strong family history of diffuse gastric carcinoma. A germline E-cadherin gene mutation was identified in this patient, her brother, and three first cousins. All five family members underwent endoscopic evaluations, which were negative for malignancy, and elected to undergo a prophylactic total gastrectomy with Roux-en-Y esophagojejunostomy.
RESULTS: Pathologic examination of the proband's stomach revealed several microscopic foci of intramucosal signet ring cell adenocarcinoma in the cardia and proximal gastric body. Postgastrectomy specimens from the proband's brother and three first cousins all showed intramucosal signet ring cell adenocarcinoma in various regions of the stomach. Immunoperoxidase studies performed on gastric tissue from these five patients demonstrated diminished or absent E-cadherin reactivity in the cancerous mucosa.
CONCLUSIONS: Although total gastrectomy was performed as a prophylactic intervention, occult gastric carcinoma was discovered in all five patients. Thus, total gastrectomy should be curative for gastric carcinoma in these patients. Based on their successful outcomes and the lack of efficacious surveillance methods for diffuse gastric carcinoma, prophylactic total gastrectomy may be the management of choice for germline E-cadherin gene mutation carriers. However, prophylactic total gastrectomy should be undertaken cautiously because the procedure may be associated with considerable morbidity. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443625     DOI: 10.1002/1097-0142(20010701)92:1<181::aid-cncr1307>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Presumption, privilege, and preemption.

Authors:  Murray F Brennan
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

3.  Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.

Authors:  Jennifer Muir; Melyssa Aronson; Mary-Jane Esplen; Aaron Pollett; Carol J Swallow
Journal:  J Gastrointest Surg       Date:  2016-10-17       Impact factor: 3.452

4.  Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

Authors:  D Shaw; V Blair; A Framp; P Harawira; M McLeod; P Guilford; S Parry; A Charlton; I Martin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 5.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

6.  Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function.

Authors:  Jin-Lian Chen; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Tong Zhou; Ming Yao; Dong-Qing Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 7.  CDH1 germline mutation in hereditary gastric carcinoma.

Authors:  Hai-Dan Wang; Jun Ren; Lian Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

Review 8.  10 rare tumors that warrant a genetics referral.

Authors:  Kimberly C Banks; Jessica J Moline; Monica L Marvin; Anna C Newlin; Kristen J Vogel
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

9.  Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.

Authors:  R C Fitzgerald; C Caldas
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  A short guide to hereditary diffuse gastric cancer.

Authors:  Parry Guilford; Vanessa Blair; Helen More; Bostjan Humar
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.